Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Saudi Arabia · Delayed Price · Currency is SAR 212.60
-2.00 (-0.93%)
Jun 11, 2026, 3:13 PM AST
TADAWUL:4013 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,985 | 13,707 | 11,200 | 9,508 | 8,311 | 7,250 | |
Revenue Growth (YoY) | 18.15% | 22.38% | 17.79% | 14.41% | 14.62% | 23.69% |
Cost of Revenue | 9,863 | 9,513 | 7,471 | 6,255 | 5,578 | 4,934 |
Gross Profit | 4,121 | 4,194 | 3,730 | 3,254 | 2,733 | 2,316 |
Selling, General & Admin | 1,541 | 1,575 | 1,373 | 1,158 | 1,032 | 850.28 |
Operating Expenses | 1,541 | 1,575 | 1,373 | 1,158 | 1,032 | 850.28 |
Operating Income | 2,581 | 2,619 | 2,356 | 2,096 | 1,700 | 1,466 |
Interest Expense | -364.26 | -338.8 | -162.76 | -70.11 | -49.36 | -37.9 |
Interest & Investment Income | 52.71 | 52.71 | 56.76 | 82.13 | 40.72 | 9.9 |
Earnings From Equity Investments | 21.94 | 22.74 | 20.99 | 22.18 | 19.61 | 7.49 |
Other Non Operating Income (Expenses) | 177.92 | 163.64 | 97.93 | 40.14 | 85.2 | 55.7 |
EBT Excluding Unusual Items | 2,469 | 2,519 | 2,369 | 2,170 | 1,797 | 1,501 |
Gain (Loss) on Sale of Investments | - | - | 43.68 | - | - | - |
Pretax Income | 2,469 | 2,519 | 2,413 | 2,170 | 1,797 | 1,501 |
Income Tax Expense | 43.84 | 27.61 | 42.9 | 68.52 | 107.71 | 114.07 |
Earnings From Continuing Operations | 2,425 | 2,492 | 2,370 | 2,101 | 1,689 | 1,387 |
Minority Interest in Earnings | -77.52 | -90.19 | -54.67 | -55.46 | -38.2 | -10.66 |
Net Income | 2,348 | 2,401 | 2,315 | 2,046 | 1,651 | 1,377 |
Net Income to Common | 2,348 | 2,401 | 2,315 | 2,046 | 1,651 | 1,377 |
Net Income Growth | 1.14% | 3.72% | 13.16% | 23.95% | 19.91% | 30.43% |
Shares Outstanding (Basic) | 350 | 350 | 350 | 350 | 350 | 350 |
Shares Outstanding (Diluted) | 350 | 350 | 350 | 350 | 350 | 350 |
EPS (Basic) | 6.71 | 6.86 | 6.62 | 5.85 | 4.72 | 3.93 |
EPS (Diluted) | 6.71 | 6.86 | 6.62 | 5.85 | 4.72 | 3.93 |
EPS Growth | 1.14% | 3.72% | 13.16% | 23.95% | 19.91% | 30.43% |
Free Cash Flow | 1,202 | 418.64 | -858.19 | -252.74 | 1,330 | 929.27 |
Free Cash Flow Per Share | 3.43 | 1.20 | -2.45 | -0.72 | 3.80 | 2.65 |
Dividend Per Share | 3.710 | 4.830 | 4.770 | 4.320 | 3.480 | 2.800 |
Dividend Growth | -21.40% | 1.26% | 10.42% | 24.14% | 24.29% | 33.33% |
Gross Margin | 29.47% | 30.60% | 33.30% | 34.22% | 32.88% | 31.95% |
Operating Margin | 18.45% | 19.11% | 21.04% | 22.04% | 20.46% | 20.22% |
Profit Margin | 16.79% | 17.52% | 20.67% | 21.52% | 19.86% | 18.99% |
Free Cash Flow Margin | 8.59% | 3.05% | -7.66% | -2.66% | 16.01% | 12.82% |
EBITDA | 3,216 | 3,193 | 2,711 | 2,358 | 1,960 | 1,728 |
EBITDA Margin | 23.00% | 23.29% | 24.20% | 24.80% | 23.59% | 23.84% |
D&A For EBITDA | 635.32 | 573.95 | 354.76 | 262.57 | 259.77 | 262.11 |
EBIT | 2,581 | 2,619 | 2,356 | 2,096 | 1,700 | 1,466 |
EBIT Margin | 18.45% | 19.11% | 21.04% | 22.04% | 20.46% | 20.22% |
Effective Tax Rate | 1.77% | 1.10% | 1.78% | 3.16% | 6.00% | 7.60% |
Advertising Expenses | - | 73.14 | 42.05 | 35.72 | 32.82 | 22.79 |